cheisi:	iranchiese@darmanyab.com

Technological investments in production activities are also progressing alongside the development of more complex and up-to-date pharmaceutical formulations. Work to build a new Research and Development Centre in Parma will begin by the end of the year, which will enable us to combine both internal activities and collaborative projects with external scientific organisations in newly equipped premises on a single site.

Objectives for 2008

In 2008, we have planned for significant growth, which will be driven by increased sales of Foster in a number of European countries; increased sales are also expected for our other Corporate products: Clenil, Curosurf, Bramitob and Clipper.

Our German affiliate Asche Chiesi has acquired direct sales of Curosurf in its territory since January this year; plans have also been made for a similar operation in China which should take place this summer, when a new Group affiliate will be opened in this enormous market.

We are currently studying further opportunities for geographical expansion in a small number of expanding markets, in order to ensure optimum development of our new Corporate products.

<Back  (1-2-3-4)  Next>

►Mission & Vision  Darmanyab Darou's first objective is making health accessible to  ...

►Business Development Darmanyab Darou is a fast growing company with an active ...

the best resolution for view: 1280 x 1024